Related references
Note: Only part of the references are listed.Synthesis and evaluation of peptide-fentanyl analogue conjugates as dual μ/δ-opioid receptor agonists for the treatment of pain
Jing Li et al.
CHINESE CHEMICAL LETTERS (2022)
Bifunctional Opioid/Melanocortin Peptidomimetics for Use in Neuropathic Pain: Variation in the Type and Length of the Linker Connecting the Two Pharmacophores
Ewa Witkowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Selective G protein signaling driven by substance P-neurokinin receptor dynamics
Julian A. Harris et al.
NATURE CHEMICAL BIOLOGY (2022)
Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns
Adrian Ricarte et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)
Optimization of bifunctional piperidinamide derivatives as σ1R Antagonists/MOR agonists for treating neuropathic pain
Jiaying Xiong et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Bifunctional μ opioid and σ1 receptor ligands as novel analgesics with reduced side effects
Tao Zhuang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
GPCRdb in 2021: integrating GPCR sequence, structure and function
Albert J. Kooistra et al.
NUCLEIC ACIDS RESEARCH (2021)
A Genetically Encoded F-19 NMR Probe Reveals the Allosteric Modulation Mechanism of Cannabinoid Receptor 1
Xiaoyan Wang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Structural insights into the human D1 and D2 dopamine receptor signaling complexes
Youwen Zhuang et al.
CELL (2021)
Structures of the σ2, receptor enable docking for bioactive ligand discovery
Assaf Alon et al.
NATURE (2021)
Structures of the human dopamine D3 receptor-Gi complexes
Peiyu Xu et al.
MOLECULAR CELL (2021)
How μ-opioid receptor recognizes fentanyl
Quynh N. Vo et al.
NATURE COMMUNICATIONS (2021)
Structures of neurokinin 1 receptor in complex with Gq and Gs proteins reveal substance P binding mode and unique activation features
Cristian Thom et al.
SCIENCE ADVANCES (2021)
Novel Dual-Target μ-Opioid Receptor and Dopamine D3 Receptor Ligands as Potential Nonaddictive Pharmacotherapeutics for Pain Management
Alessandro Bonifazi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Kinetics and Mechanism of Fentanyl Dissociation from the μ-Opioid Receptor
Paween Mahinthichaichan et al.
JACS AU (2021)
Opioids and Their Endocrine Effects: A Systematic Review and Meta-analysis
Friso de Vries et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Efficacy and safety of the first-in-class imidazoline-2 receptor ligand CR4056 in pain from knee osteoarthritis and disease phenotypes: a randomized, double-blind, placebo-controlled phase 2 trial
L. C. Rovati et al.
OSTEOARTHRITIS AND CARTILAGE (2020)
Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures
Tian Hua et al.
CELL (2020)
4-Aryl-1-oxa-4,9-diazaspiro[5.5]undecane Derivatives as Dual μ-Opioid Receptor Agonists and σ1 Receptor Antagonists for the Treatment of Pain
Monica Garcia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Imidazoline Receptor System: The Past, the Present, and the Future
Pascal Bousquet et al.
PHARMACOLOGICAL REVIEWS (2020)
Haloperidol bound D2 dopamine receptor structure inspired the discovery of subtype selective ligands
Luyu Fan et al.
NATURE COMMUNICATIONS (2020)
Impact of GPCR Structures on Drug Discovery
Miles Congreve et al.
CELL (2020)
Piperidine propionamide as a scaffold for potent sigma-1 receptor antagonists and mu opioid receptor agonists for treating neuropathic pain
Jiaying Xiong et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
DARK Classics in Chemical Neuroscience: Carfentanil
Anna E. Ringuette et al.
ACS CHEMICAL NEUROSCIENCE (2020)
The Expanding Role of the COX Inhibitor/Opioid Receptor Agonist Combination in the Management of Pain
Giustino Varrassi et al.
DRUGS (2020)
Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective
Li Zhang et al.
FRONTIERS IN PHARMACOLOGY (2020)
Potential Energy Function for Fentanyl-Based Opioid Pain Killers
Samo Lesnik et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors
Amy J. Eshleman et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Antinociceptive and Cytotoxic Activity of Opioid Peptides with Hydrazone and Hydrazide Moieties at the C-Terminus
Jolanta Dyniewicz et al.
MOLECULES (2020)
Structure of a D2 dopamine receptor-G-protein complex in a lipid membrane
Jie Yin et al.
NATURE (2020)
Novel hybrid compounds, opioid agonist plus melanocortin 4 receptor antagonist, as efficient analgesics in mouse chronic constriction injury model of neuropathic pain
Joanna Starnowska-Sokol et al.
NEUROPHARMACOLOGY (2020)
Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ1 Receptor Antagonist Clinical Candidate for the Treatment of Pain
Monica Garcia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Optimized Opioid-Neurotensin Multitarget Peptides: From Design to Structure-Activity Relationship Studies
Simon Gonzalez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Multifunctional Opioid-Derived Hybrids in Neuropathic Pain: Preclinical Evidence, Ideas and Challenges
Joanna Starnowska-Sokol et al.
MOLECULES (2020)
Structure of the dopamine D2 receptor in complex with the antipsychotic drug spiperone
Dohyun Im et al.
NATURE COMMUNICATIONS (2020)
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases
Na Ye et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
μ-Opioid/D2 dopamine receptor pharmacophore containing ligands: Synthesis and pharmacological evaluation
Ivana I. Jevtic et al.
JOURNAL OF THE SERBIAN CHEMICAL SOCIETY (2020)
Synthesis and Biological Evaluation of Fentanyl Analogues Modified at Phenyl Groups with Alkyls
Yajuan Qin et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Fentanyl Family at the Mu-Opioid Receptor: Uniform Assessment of Binding and Computational Analysis
Piotr F. J. Lipinski et al.
MOLECULES (2019)
Human substance P receptor binding mode of the antagonist drug aprepitant by NMR and crystallography
Shuanghong Chen et al.
NATURE COMMUNICATIONS (2019)
Preparation of bivalent agonists for targeting the mu opioid and cannabinoid receptors
Szabolcs Dvoracsko et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Molecular dynamics of fentanyl bound to -opioid receptor
Piotr F. J. Lipinski et al.
JOURNAL OF MOLECULAR MODELING (2019)
A New Pharmacophore Model for the Design of Sigma-1 Ligands Validated on a Large Experimental Dataset
Rosalia Pascual et al.
FRONTIERS IN PHARMACOLOGY (2019)
The Molecular Function of σ Receptors: Past, Present, and Future
Hayden R. Schmidt et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Structure of an allosteric modulator bound to the CB1 cannabinoid receptor
Zhenhua Shao et al.
NATURE CHEMICAL BIOLOGY (2019)
Crystal structure of dopamine receptor D4 bound to the subtype selective ligand, L745870
Ye Zhou et al.
ELIFE (2019)
Toward a Universal μ-Agonist Template for Template-Based Alignment Modeling of Opioid Ligands
Zhijun Wu et al.
ACS OMEGA (2019)
Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex
Kaavya Krishna Kumar et al.
CELL (2019)
The Fentanyl Epidemic and Evolution of Fentanyl Analogs in the United States and the European Union
Paul J. Jannetto et al.
CLINICAL CHEMISTRY (2019)
Neurokinin-1 receptor-based bivalent drugs in pain management: The journey to nowhere?
Patrycja Kleczkowska et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists
Jendrik Schoeppe et al.
NATURE COMMUNICATIONS (2019)
Affinity of fentanyl and its derivatives for the σ1-receptor
Piotr F. J. Lipinski et al.
MEDCHEMCOMM (2019)
Synthetic route towards potential bivalent ligands possessing opioid and D2/D3 pharmacophores
Ivana I. Jevtic et al.
JOURNAL OF THE SERBIAN CHEMICAL SOCIETY (2019)
Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations
Yoonji Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
DARK Classics in Chemical Neuroscience: Fentanyl
S. Mallory Burns et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Design, Synthesis, and Biological Evaluation of Bivalent Ligands Targeting Dopamine D2-Like Receptors and the -Opioid Receptor
Mingcheng Qian et al.
CHEMMEDCHEM (2018)
Sigma-2 receptor: past, present and perspectives on multiple therapeutic exploitations
Carmen Abate et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Molecular Consortia-Various Structural and Synthetic Concepts for More Effective Therapeutics Synthesis
Anna Pawelczyk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone
Sheng Wang et al.
NATURE (2018)
Structure of the μ-opioid receptor-Gi protein complex
Antoine Koehl et al.
NATURE (2018)
New approaches and challenges to targeting the endocannabinoid system
Vincenzo Di Marzo
NATURE REVIEWS DRUG DISCOVERY (2018)
Structural basis for σ1 receptor ligand recognition
Hayden R. Schmidt et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Crystal structure of the human NK1 tachykinin receptor
Jie Yin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Advances in Achieving Opioid Analgesia Without Side Effects
Halina Machelska et al.
FRONTIERS IN PHARMACOLOGY (2018)
A Convenient Methanolysis in the Synthesis of Carfentanyl
Eerold Vellemae et al.
ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL (2018)
(+)-and (-)-Phenazocine enantiomers: Evaluation of their dual opioid agonist/σ1 antagonist properties and antinociceptive effects
O. Prezzavento et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis
Antonio Rescifina et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors
Adriano Mollica et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Crystal structures of agonist-bound human cannabinoid receptor CB1
Tian Hua et al.
NATURE (2017)
Imidazoline I2 receptors: An update
Jun-Xu Li
PHARMACOLOGY & THERAPEUTICS (2017)
D4 dopamine receptor high-resolution structures enable the discovery of selective agonists
Sheng Wang et al.
SCIENCE (2017)
Synthesis of Orthogonally Protected (±)-3-Amino-4-anilidopiperidines and (±)-3-N-Carbomethoxyfentanyl
Ivana I. Jevtic et al.
SYNTHESIS-STUTTGART (2017)
Neuropathic pain
Luana Colloca et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
The FMO analysis of the molecular interaction of fentanyl derivatives with the μ-opioid receptor
Malgorzata Jaronczyk et al.
CHEMICAL PAPERS (2017)
Differential Opioid Tolerance and Opioid-induced Hyperalgesia A Clinical Reality
Christina J. Hayhurst et al.
ANESTHESIOLOGY (2016)
Crystal Structure of the Human Cannabinoid Receptor CB1
Tian Hua et al.
CELL (2016)
Multitarget opioid ligands in pain relief: New players in an old game
Rita Turnaturi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Evaluation of the analgesic effect of 4-anilidopiperidine scaffold containing ureas and carbamates
Ludovica Monti et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment
Vivek Kumar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Structure-Based Optimization of Multifunctional Agonists for Opioid and Neuropeptide FF Receptors with Potent Nontolerance Forming Analgesic Activities
Zi-Long Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Crystal structure of the human σ1 receptor
Hayden R. Schmidt et al.
NATURE (2016)
High-resolution crystal structure of the human CB1 cannabinoid receptor
Zhenhua Shao et al.
NATURE (2016)
Dopamine D2/3-and μ-opioid receptor antagonists reduce cue-induced responding and reward impulsivity in humans
S. C. Weber et al.
TRANSLATIONAL PSYCHIATRY (2016)
The design of multitarget ligands for chronic and neuropathic pain
Szabolcs Dvoracsko et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Structural insights into μ-opioid receptor activation
Weijiao Huang et al.
NATURE (2015)
Receptome: Interactions between three pain-related receptors or the Triumvirate of cannabinoid, opioid and TRPV1 receptors
Ferenc Zador et al.
PHARMACOLOGICAL RESEARCH (2015)
Design, Synthesis and Biological Evaluation of Two Opioid Agonist and Ca(v)2.2 Blocker Multitarget Ligands
Adriano Mollica et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2015)
Selective sigma-1 receptor antagonists for the treatment of pain
Carmen Almansa et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications
Ruben S. Vardanyan et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Micromolar concentrations of rimonabant directly inhibits delta opioid receptor specific ligand binding and agonist-induced G-protein activity
Ferenc Zador et al.
NEUROCHEMISTRY INTERNATIONAL (2014)
Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides
J. Fichna et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2014)
An Efficient, Optimized Synthesis of Fentanyl and Related Analogs
Carlos A. Valdez et al.
PLOS ONE (2014)
Conference on 'PUFA mediators: implications for human health' Symposium 3: Cannabinoids in human health Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications
Roger G. Pertwee
PROCEEDINGS OF THE NUTRITION SOCIETY (2014)
Synthesis of 4-anilinopiperidine methyl esters, intermediates in the production of carfentanil, sufentanil, and remifentanil
Andrew J. Walz et al.
TETRAHEDRON LETTERS (2014)
Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effects
Alba Vidal-Torres et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Sigma 1 receptor: A new therapeutic target for pain
Daniel Zamanillo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Latest advances in the discovery of fatty acid amide hydrolase inhibitors
Tiziana Bisogno et al.
EXPERT OPINION ON DRUG DISCOVERY (2013)
Bivalent Ligands That Target μ Opioid (MOP) and Cannabinoid1 (CB1) Receptors Are Potent Analgesics Devoid of Tolerance
Morgan Le Naour et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Potentiation of morphine-induced mechanical antinociception by σ1 receptor inhibition: Role of peripheral σ1 receptors
Cristina Sanchez-Fernandez et al.
NEUROPHARMACOLOGY (2013)
Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization
L. Romero et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
A Convenient Route to 4-Carboxy-4-Anilidopiperidine Esters and Acids
Janos Marton et al.
MOLECULES (2012)
Crystal structure of the μ-opioid receptor bound to a morphinan antagonist
Aashish Manglik et al.
NATURE (2012)
Inhibition of forebrain μ-opioid receptor signaling by low concentrations of rimonabant does not require cannabinoid receptors and directly involves μ-opioid receptors
Ferenc Zador et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies
Kathryn A. Seely et al.
NEUROPHARMACOLOGY (2012)
Laboratory and industrial synthesis of remifentanil
Frantisek Mathia et al.
ACTA CHIMICA SLOVACA (2012)
Synthesis and biological evaluation of new opioid agonist and neurokinin-1 antagonist bivalent ligands
Ruben Vardanyan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Effect of acute and continuous morphine treatment on transcription factor expression in subregions of the rat caudate putamen. Marked modulation by D4 receptor activation
Belen Gago et al.
BRAIN RESEARCH (2011)
Imidazoline I2 receptors: Target for new analgesics?
Jun-Xu Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Carba-Analogues of Fentanyl are Opioid Receptor Agonists
Grazyna Weltrowska et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
PK20, a new opioid-neurotensin hybrid peptide that exhibits central and peripheral antinociceptive effects
Patrycja Kleczkowska et al.
MOLECULAR PAIN (2010)
σ1 Receptor Modulation of G-Protein-Coupled Receptor Signaling: Potentiation of Opioid Transduction Independent from Receptor Binding
Felix J. Kim et al.
MOLECULAR PHARMACOLOGY (2010)
Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist
Ellen Y. T. Chien et al.
SCIENCE (2010)
Synthesis and investigations of double-pharmacophore ligands for treatment of chronic and neuropathic pain
Ruben Vardanyan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Identification of an imidazoline binding protein: Creatine kinase and an imidazoline-2 binding site
Atsuko Kimura et al.
BRAIN RESEARCH (2009)
Sigma-1 receptors regulate activity-induced spinal sensitization and neuropathic pain after peripheral nerve injury
Beatriz de la Puente et al.
PAIN (2009)
Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors
Jose M. Entrena et al.
PSYCHOPHARMACOLOGY (2009)
Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance
T. Trang et al.
NEUROSCIENCE (2007)
Dopamine D4 receptor activation decreases the expression of μ-opioid receptors in the rat striatum
Belen Gago et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2007)
Partial retro-inverso, retro, and inverso modifications of hydrazide linked bifunctional peptides for opioid and cholecystokinin (CCK) receptors
Yeon Sun Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the μ-opioid receptor and I2-imidazoline binding sites
Christophe Dardonville et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Structure-activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors
Richard S. Agnes et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
In vivo evaluation of (+)-MR200 as a new selective sigma ligand modulating MOP, DOP and KOP supraspinal analgesia
A Marrazzo et al.
LIFE SCIENCES (2006)
Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice
CM Cendán et al.
PSYCHOPHARMACOLOGY (2005)
Designed multiple ligands. An emerging drug discovery paradigm
R Morphy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Discovery of high-affinity ligands of σ1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening
C Laggner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure
MH Ossipov et al.
BIOPOLYMERS (2005)
Fentanyl derivatives bearing aliphatic alkaneguanidinium moieties:: a new series of hybrid molecules with significant binding affinity for μ-opioid receptors and I2-imidazoline binding sites
C Dardonville et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Ultrastructural evidence for co-localization of dopamine D2 and μ-opioid receptors in the rat dorsolateral striatum
LM Ambrose et al.
ANATOMICAL RECORD PART A-DISCOVERIES IN MOLECULAR CELLULAR AND EVOLUTIONARY BIOLOGY (2004)
The synthesis and preliminary pharmacological evaluation of the racemic cis and trans 3-alkylfentanyl analogues
MD Ivanovic et al.
JOURNAL OF THE SERBIAN CHEMICAL SOCIETY (2004)
Inhibition of neurokinin-1-substance P receptor and prostanoid activity prevents and reverses the development of morphine tolerance in vivo and the morphine-induced increase in CGRP expression in cultured dorsal root ganglion neurons
KJ Powell et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
μ-Receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man
N Hagelberg et al.
SYNAPSE (2002)
Guanidinium and aminoimidazolinium derivatives of N-(4-piperidyl)propanamides as potential ligands for μ opioid and I2-imidazoline receptors:: Synthesis and pharmacological screening
A Montero et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2002)
The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behavior in alcohol-preferring rats
S Serra et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Region specific increase of dopamine receptor D1/D2 mRNA expression in the brain of μ-opioid receptor knockout mice
Y Park et al.
BRAIN RESEARCH (2001)
Share Paper
